(Created page with "{{Medical Device |Health Topic=Maternal mortality, |Classification=Preventative |Scope=Commercialized |Location=Africa, Asia, Australia, Europe, North America, South America |Im...") |
No edit summary |
||
Line 1: | Line 1: | ||
{{Medical Device | {{Medical Device | ||
|Health Topic=Maternal mortality, | |Health Topic=Maternal mortality, | ||
|Classification=Preventative | |Classification=Preventative | ||
|Scope=Commercialized | |Scope=Commercialized | ||
Line 11: | Line 11: | ||
==Detailed description of the solution== | ==Detailed description of the solution== | ||
This device is a low signal oximetry sensor that uses occlusion spectroscopy. Pressure is applied by a sensor around the finger, which obstructs blood flow. An optical signal is measured with a blood specific high signal to noise ratio. Therefore this device allows for accurate oximetry measurements even in times of low perfusion. It can measure glucose and hemoglobin levels as well as pulse rate. | This device is a low signal oximetry sensor that uses occlusion spectroscopy. Pressure is applied by a sensor around the finger, which obstructs blood flow. An optical signal is measured with a blood specific high signal to noise ratio. Therefore this device allows for accurate oximetry measurements even in times of low perfusion. It can measure glucose and hemoglobin levels as well as pulse rate. | ||
==Designed by== | ==Designed by== | ||
*Designed by: OriSense | *Designed and manufactured by: OriSense, located in Israel. | ||
==When and where it was tested/implemented == | ==When and where it was tested/implemented == | ||
It was tested through multi center trials in cities across Europe and U.S. | |||
==References== | ==References== | ||
Line 25: | Line 24: | ||
===Other internally generated reports=== | ===Other internally generated reports=== | ||
===Externally generated reports=== | ===Externally generated reports=== | ||
Pulse oximetry. Fearnley S.J. (1995). Update in Anaesthesia Issue 5, article | Pulse oximetry. Fearnley S.J. (1995). Update in Anaesthesia Issue 5, article. | ||
Pulse oximetry. Jubran A. (1999). Critical Care 3: R11-R17 | Pulse oximetry. Jubran A. (1999). Critical Care 3: R11-R17 | ||
Is Hypoxia common despite oxygen treatment in the Acute Medical Ward? Dhar R, Harrison RN, Snashall PD. (2006) Internet Journal of Medical update 1(2) | Is Hypoxia common despite oxygen treatment in the Acute Medical Ward? Dhar R, Harrison RN, Snashall PD. (2006) Internet Journal of Medical update 1(2). | ||
Revision as of 11:30, 19 June 2012
Problem being addressed
Post-Partum hemorrhage is the cause for 8% of direct pregnancy-related deaths in industrialized countries and 25% of maternal deaths in the developing world. In trauma patients, hemorrhagic shock is the second most frequent cause of death.
Detailed description of the solution
This device is a low signal oximetry sensor that uses occlusion spectroscopy. Pressure is applied by a sensor around the finger, which obstructs blood flow. An optical signal is measured with a blood specific high signal to noise ratio. Therefore this device allows for accurate oximetry measurements even in times of low perfusion. It can measure glucose and hemoglobin levels as well as pulse rate.
Designed by
- Designed and manufactured by: OriSense, located in Israel.
When and where it was tested/implemented
It was tested through multi center trials in cities across Europe and U.S.
References
Peer-reviewed publication
Other internally generated reports
Externally generated reports
Pulse oximetry. Fearnley S.J. (1995). Update in Anaesthesia Issue 5, article.
Pulse oximetry. Jubran A. (1999). Critical Care 3: R11-R17 Is Hypoxia common despite oxygen treatment in the Acute Medical Ward? Dhar R, Harrison RN, Snashall PD. (2006) Internet Journal of Medical update 1(2).